Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.20% | 61.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.20% | 61.92% | |||
| Cost of Revenue | -1.18% | 91.22% | |||
| Gross Profit | -1.21% | 46.04% | |||
| SG&A Expenses | -1.20% | -0.32% | |||
| Depreciation & Amortization | -1.15% | -14.52% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.20% | 41.63% | |||
| Operating Income | 1.20% | -39.98% | |||
| Income Before Tax | 1.20% | -35.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.20% | -35.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.20% | -35.64% | |||
| EBIT | 1.20% | -39.98% | |||
| EBITDA | 0.85% | -41.99% | |||
| EPS Basic | 1.60% | -20.19% | |||
| Normalized Basic EPS | 1.28% | -20.00% | |||
| EPS Diluted | 1.60% | -20.19% | |||
| Normalized Diluted EPS | 1.28% | -20.00% | |||
| Average Basic Shares Outstanding | 0.00% | 12.73% | |||
| Average Diluted Shares Outstanding | 0.00% | 12.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||